Search clinical trials for: 5-HT3 antagonist

Total 38882 results

Anne Katrine Pagsberg
Albert Einstein College of Medicine; The Research Council for Health and Disease... and other collaborators

Unknown

Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA)

Psychosis

Denmark
Otsuka Pharmaceutical Development & Commercialization...

Completed

An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia

Schizophrenia

United States
Yoo-Sook Joung
Korea Otsuka International Asia Arab

Unknown

Study to Evaluate the Efficacy and Safety of Aripiprazole

Autism

Korea, Republic of, Philippines, Thailand
Otsuka Pharmaceutical Co., Ltd.

Completed

Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-

Schizophrenia

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
University of North Carolina, Chapel Hill
Bristol-Myers Squibb

Completed

Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine

Mood Disorders | Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

Autistic Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)

Behavioral Symptoms | Autistic Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

Behavioral Symptoms | Autistic Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode

Bipolar Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

Bipolar I Disorder

United States, Argentina
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia

Schizophrenia

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia

Dementia | Alzheimer's Disease

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients

Schizophrenia

Turkey, Austria, Germany, South Africa, Sweden, Finland, Czech Republic, Poland, France, Hungary, United Kingdom, Switzerland
Otsuka Pharmaceutical Development & Commercialization...

Completed

Oral Aripiprazole Open-Label Rollover Study

Schizophrenia

Russian Federation, Argentina, Croatia, India, Serbia, Ukraine
Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Completed

Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder

Tourette's Disorder | Chronic Motor or Vocal Tic Disorder

Korea, Republic of
University of Sao Paulo

Unknown

Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients (ARIQUELI)

Bipolar I Disorder

Brazil
Otsuka Pharmaceutical Development & Commercialization...

Completed

Aripiprazole Open-Label, Safety and Tolerability Study (APEX 241)

Schizophrenia | Bipolar Disorder

United States
Massachusetts General Hospital
Bristol-Myers Squibb

Completed

The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression (Abilify)

Psychotic Depression

United States
Louisiana State University Health Sciences Center...
Bristol-Myers Squibb

Terminated

Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)

Schizophrenia | Schizoaffective Disorder

United States
Lindner Center of HOPE
University of Cincinnati

Completed

A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression

Bipolar Depression

United States
AstraZeneca

Completed

Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects

Alzheimer's Disease

Sweden
Taoyuan Psychiatric Center, Ministry of Health...
Department of Health

Unknown

Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia

Dyskinesia, Drug-Induced

Taiwan
Taiwan Otsuka Pharm. Co., Ltd

Completed

Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder

Taiwan
Federal University of São Paulo

Completed

Aripiprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms (AripipPTSD)

Posttraumatic Stress Disorder
Tata Memorial Hospital

Completed

Granisetron Versus Ondansetron: Comparative Effects on ECG, QTc

Prolonged QTc Interval

India
All India Institute of Medical Sciences, Bhubaneswar

Recruiting

Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia

Schizophrenia

India
Consorcio Centro de Investigación Biomédica en...
Instituto de Salud Carlos III

Not yet recruiting

Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis (SchizOMICS)

Diabetes | Schizophrenia | Lipid Metabolism Disorders | NAFLD | Psychosis | Treatment-resistant Schizophrenia | Side Effect
Otsuka Pharmaceutical Development & Commercialization...
PRA Health Sciences

Completed

A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder

Schizophrenia | Bipolar I Disorder

United States
Ain Shams University

Completed

Impact of Aripiprazole on Postoperative Analgesia in Laparoscopic Hysterectomy

Analgesia | Anesthesia | Hysterotomy

Egypt
University of Medicine and Dentistry of New Jersey

Completed

Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children (Abilify)

Autism

United States
University of Copenhagen

Completed

Pan European Collaboration on Antipsychotic Naïve Schizophrenia II (PECANSII)

Schizophrenia

Denmark
Chonbuk National University Hospital
Otsuka Pharmaceutical Co., Ltd.

Completed

Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients

Schizophrenia

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

A Multicenter Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With Schizophrenia

Schizophrenia

Japan
Kettering Health Network

Terminated

Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia (BEST)

Schizophrenia

United States
Fundación Marques de Valdecilla
Centro de Investigación Biomédica en Red de Salud Mental; Instituto de Investigación...

Unknown

Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up (PAFIP3_1Y)

Psychotic Disorders | Schizophrenia

Spain
Medical University of South Carolina

Completed

Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART) (BAART)

Autistic Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia

Schizophrenia

United States
Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Unknown

Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition

Bioequivalence

China
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia

Schizophrenia

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder

Autistic Disorder

Japan
Craig Rush
National Institute on Drug Abuse (NIDA)

Completed

Aripiprazole to Reduce Cocaine Relapse

Cocaine-Related Disorders

United States
Northwell Health
National Institute of Mental Health (NIMH)

Completed

Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis

Schizophrenia

United States
St. Luke's-Roosevelt Hospital Center
Bristol-Myers Squibb

Completed

Abilify as an Adjunctive Treatment for Refractory Depression

Depressive Disorder, Major

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia (STEP 203)

Schizophrenia

United States, Croatia, Serbia, Bulgaria, India, Korea, Republic of, Philippines, Romania, Russian Federation, Slovakia, Taiwan, Ukraine
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia

Nervous System Diseases | Schizophrenia | Mental Disorder

United States
University of Oxford
National Institute for Health Research, United Kingdom

Completed

Aripiprazole and Prolactin Study (APS)

Hyperprolactinemia

United Kingdom
Otsuka Pharmaceutical Development & Commercialization...

Withdrawn

Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder

Nervous System Diseases | Schizophrenia | Mental Disorder | Bipolar 1 Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials

Schizophrenia

France, South Africa, Canada, Russian Federation, Poland, Czech Republic, Hungary, Croatia, Netherlands, Romania, United Kingdom
University Hospitals Cleveland Medical Center
Bristol-Myers Squibb

Completed

Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)

Attention Deficit Hyperactivity Disorder

United States

Search clinical trials for: 5-HT3 antagonist

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations